FDA Drug Application (021005) for SOLARAZE by FOUGERA PHARMS

Back to FDA Applications sponsored by FOUGERA PHARMS

Application Number021005
Product Number001
FormGEL;TOPICAL
Dosage3%
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameSOLARAZE
Active IngredientDICLOFENAC SODIUM

Active IngredientCount
List of drugs with Active Ingredient DICLOFENAC SODIUM8


Back to FDA Applications sponsored by FOUGERA PHARMS